© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Piperazine’s story begins back in the late nineteenth century, far before the current landscape of specialty chemicals and pharmaceuticals grew as complex as it is now. For a long time, its main claim to fame rested on its emergence from coal tar distillation. Early chemists chasing the secrets of organic compounds stumbled onto piperazine while isolating substances used in munitions and dyes. In short order, its cyclical structure caught the attention of scientists who saw opportunity woven into its simplicity and reactivity. Within a few decades, doctors saw promise in piperazine for fighting intestinal worms as pharmaceutical research ramped up in the mid twentieth century. It marched into patent filings, research journals, and, more interestingly, into clinics where it brought relief from parasitic infections at a time when few medicines could offer the same.
Piperazine shows up as an industrial chemical, a starting block for medicines, and a key ingredient in several everyday products many people never notice. Its molecular structure—a six-membered ring of nitrogen and carbon—lets it wear many hats. Pharmaceutical manufacturers rely on it to build antihistamines, antidepressants, and even some antipsychotics. Water treatment engineers lean on it for corrosion inhibition in boilers and pipelines. The story gets more interesting when you learn piperazine also helps stabilize plastics, improve adhesives, and serves up chemistry classrooms with classic reactions year after year. Companies around the globe count on steady supplies. That says a lot about what happens when a chemical goes from curiosity to workhorse.
Piperazine usually presents itself as a white or colorless crystalline solid, sometimes smelling faintly ammoniacal if your nose gets close enough. It absorbs water from the air, forming a dihydrate quite easily—something that matters, especially in humid climates where storage becomes a challenge. It dissolves smoothly in water and ethanol, making it easy to use in both lab and industrial settings. Its melting and boiling points, falling in the moderate range, promote manageable handling on a production scale. Chemical stability remains decent under normal conditions, yet exposure to strong acids or oxidizers brings it to life with reactivity worth noting. Beyond numbers and tables, these traits mean piperazine manages to maintain both versatility and safety, assuming basic good sense prevails in the workplace.
No matter if it’s headed for a warehouse shelf or a hospital storeroom, regulators want piperazine to arrive labeled with concentration, purity, and hazard symbols. Purity often has to surpass 99 percent before pharmaceutical facilities sign off—anything lower risks undermining finished medicines. The industry benchmarks for contaminants set an unforgiving bar, often coming in line with pharmacopeial guidance or standards like those from the USP or BP. Shipments have to display warnings flagging irritation risks for skin, eyes, and lungs alongside storage precautions. With international movement of chemicals, labels in multiple languages become standard issue. Regulations, rooted in decades of experience, push everyone in the supply chain to double and triple check documentation and quality at every step.
Early piperazine came from unexpected places—long ago, it was coal tar and wood distillates, ugly by today’s standards but fitting for the time. Modern synthesis relies more often on the reaction of ammonia or ethylene dichloride with ethylenediamine, among other routes. Using advanced reactors, careful temperature control, and efficient distillation separates piperazine from less desirable by-products. Efficiency, yield, and reduced waste have grown to matter just as much as the final product itself. Chemistry has shifted focus over the years toward cleaner, less energy-intensive preparation. Cutting down on hazardous reagents and keeping emissions to a minimum transform the task from brute-force industry to something that walks closer to environmental responsibility. Many plants operate under tight emissions monitoring, in part because the community surrounding any chemical plant asks pointed questions about air and water quality.
A big reason piperazine found a home in laboratories and factories comes down to how well it reacts and adapts. It acts as a base, hunts down acids for salt formation, and becomes the backbone for further chemical modifications. Piperazine rings anchor a lot of new drugs, including some that treat depression and allergies. The secondary amine groups invite all manner of alkylation, acylation, and condensation. Piperazine derivatives crowd the pages of pharmaceutical patents, where minor tweaks to side chains set off big shifts in activity and function. Chemists see piperazine as a kind of stem cell for medicinal development; tweak a few atoms around that ring, and new therapeutic agents emerge, ready for clinical scrutiny. Outside the drug bench, it also crosslinks polymers, fortifies resins, and even helps synthesize insecticides.
Anyone wading into research papers or order sheets finds piperazine called by familiar and obscure names. Lab books might list it as hexahydropyrazine, diethylenediamine, or 1,4-diazacyclohexane. Older texts refer to “anthelmintic piperazine” in a nod to its pharmaceutical legacy. Product registers include official chemical abstracts listings and, sometimes, variations tied to different salt forms—piperazine citrate, piperazine adipate, and others. Every naming variation grew up in response to a real difference in use: the salt makes it more palatable, more stable, or more soluble. Those synonyms end up mattering the most in regulatory filings and importation documents, where precision trumps convenience every time.
Working with piperazine takes real diligence, both at the bench and in larger facilities. It can irritate eyes, skin, and lungs, especially in powder or vapor form. Overexposure, rare though it might seem, runs the risk of neurological symptoms and organ strain. To keep these dangers in check, workplaces install local exhaust ventilation, insist on gloves and goggles, and run periodic air monitoring. Safety data sheets must stay current and accessible. Spill kits, eyewash stations, and training run alongside routine safety talks, because industry experience shows that small lapses lead to costly accidents. Transportation and storage cut out risks related to heat and moisture—no one wants to discover degraded or caked-up product at delivery. National and international rules, like those from OSHA or REACH, lay out minimum expectations, but plants with strong safety cultures often go well beyond the rulebook.
Doctors know piperazine mostly as an old but reliable medicine for treating roundworm and pinworm infections. It once featured prominently in deworming efforts across much of the developing world. Pharmaceutical chemistry, though, took piperazine far beyond the clinic. Its chemical backbone underpins antipsychotics like quetiapine and antihistamines such as cetirizine. Polymer scientists also value it for building epoxy hardeners, helping toughen up surfaces from factory floors to electronics boards. Water utilities trust it to block scale buildup in boiler systems, keeping machinery humming for years. Even agricultural researchers use it to modify pesticide molecules. This spread of applications brings piperazine into conversation among people working in medicine, engineering, public health, and farming. That kind of cross-sector impact doesn’t just happen; it stems from a compound providing real value where better-known alternatives fall short.
Research around piperazine hasn’t sat still. Drug developers continuously hunt for new derivatives with sharper potency or gentler side effects. Small changes to the core ring structure can shift a molecule’s receptor profile or its pharmacokinetics in unpredictable ways. Scientists map out piperazine’s properties using X-ray diffraction, NMR, and advanced chromatography, all with the goal of uncovering new activities. On the materials science side, researchers look at how piperazine crosslinks with resins at the level of nanostructure. Collaboration between research labs and industry sustains this flow of new information, even as regulatory landscapes grow more intense about environmental assessments. Green chemistry circles keep tweaking preparation to use less energy and produce less waste. Ongoing toxicology studies check for subtle, longer-term health or environmental impacts, especially under repeated or large-scale use.
People working with piperazine know the concerns about occupational and environmental exposure run deep. Early on, use in deworming medicines for children prompted intense scrutiny regarding safety. At standard doses, side effects rarely reach severe levels, with nausea and dizziness topping the list. Animal studies highlight relatively low acute toxicity, but repeated overexposure threatens neurological systems and kidney function. Modern guidelines cap workplace exposure and set triggers for air monitoring. Researchers continue updating risk assessments based on animal models and human case reports. Environmental toxicologists dig into what happens to piperazine after industrial discharge, focusing on biodegradability and potential effects on aquatic life. Some studies point to moderate environmental persistence, which only sharpens the public calls for responsible handling and treatment of wastewater streams. Tougher scrutiny comes with the territory. As data trickles in from long-term monitoring, recommendations evolve, usually on the cautious side.
Piperazine stands to remain a staple for chemists and clinicians alike, but the shape of its future probably depends on the pace of new regulatory demands and public opinion about chemical safety. With pharmaceuticals racing ahead, the role of piperazine derivatives in novel drug classes looks set for further expansion, especially as more research targets hard-to-treat neurological and psychiatric conditions. Green chemistry holds the promise of cleaner production methods, building on past success with solventless or catalytic synthesis. Amid growing pressure to crack down on persistent substances, wastewater treatment technologies might pull ahead, borrowing from bioreactor and advanced oxidation ideas. Research interest in biodegradable piperazine-based polymers picks up year after year. As the world pushes harder for cleaner, safer, and more effective materials, piperazine’s flexibility keeps it in contention for both old and emerging challenges—it’s only a question of which field puts it to the test next.
Piperazine pops up in a lot of surprising places. Walk through most chemical supply warehouses and you'll find it stocked in drums or barrels. The molecule itself looks a bit like a ring with some nitrogen tossed in—not exactly eye-catching, but looks don’t tell the whole story. Over the years, I’ve seen it used in everything from pharmaceutical labs to water treatment facilities.
Piperazine’s biggest claim to fame: it fights parasites inside the human gut. Doctors have reached for it to treat pinworm and roundworm infections, especially in places where these illnesses keep families cycling through bouts of discomfort. In my own family, I’ve watched an entire rural community in Southeast Asia line up for medicine during a pinworm outbreak, and most were handed tablets with piperazine inside. The drug paralyzes the worms, so the body can flush them out. Millions of kids worldwide rely on this low-cost option, partly because newer treatments can be too expensive or tough to find.
Move away from the clinic, and piperazine still gets a lot of use. It serves as a key ingredient in making polyurethane foams—that's the stuff inside the seats of most cars and buses. People don’t talk about that sort of thing at dinner, but those foams shape how comfortable buses feel on long commutes. It’s a backbone chemical, meaning it helps produce several other big-ticket industrial compounds. Companies use it to make resins, brake fluids, and some adhesives. There’s a reason large plants in the U.S., China, and India keep running production—demand stays steady across sectors.
Where I live, folks often overlook the role chemicals play in keeping water and air clean. Piperazine makes an impact here as well. It goes into some special blends used to clean exhaust gases from power plants. The carbon capture process, important in fighting climate change, sometimes calls for piperazine or its cousins to “grab” CO₂ out of smoke before it reaches the sky. Researchers trust it for this job because it works fast and keeps down costs for the companies investing in cleaner technology.
No chemical comes risk-free. Overuse of piperazine for medical reasons can bring on some side effects—nausea, dizziness, or stomach pain—and not every parasite responds the same way. Safe handling in factories matters, too. Breathing in too much or getting it on exposed skin stings and can cause more serious health problems with enough exposure. Regulators set rules to keep workers safer, but corners sometimes get cut, especially where enforcement slices thin. From what I’ve seen on factory visits, training and protective gear stop most accidents, yet cost pressures can keep those simple measures out of reach.
Chemicals like piperazine form an unseen backbone in modern medicine and manufacturing. To keep reaping the benefits, I put my faith in strong oversight and clear communication with the people who use or work around these substances. New research on safer alternatives crops up every year, but until those options scale up, piperazine holds a vital spot in everything from public health campaigns to clean air solutions. Investments in safety, smarter usage, and ongoing study give us better odds of benefiting from this humble molecule, while shrinking the risks that come with it.
Piperazina, or piperazine, often comes up in homes and clinics as a treatment for worm infections like pinworm and roundworm. It’s sold in many countries and stands as a medicine families turn to after advice from pharmacists or doctors. The recommended dose depends on age, weight, and the specific type of worm infection.
For adults and children over eight, common guidelines suggest a single dose ranges from 3.5 to 4 grams per day, usually given for two consecutive days. The doctor or pharmacist checks the body weight to get this just right—about 75 mg to 100 mg per kilogram each day. For younger children, the dose comes down. Most recommend about 40 mg to 75 mg per kilogram of body weight, often split between morning and evening. Liquid forms make it easier for parents to measure and give the medicine accurately.
If you’ve ever had to treat a child for pinworms at home, you know keeping up with repeat doses matters. Sometimes a second course goes out after two weeks, hitting any newly hatched worms. For roundworm, health workers may prescribe two full days of treatment. Following instructions is important to cut the risk of reinfection and to protect others in the household.
Accurate dosing avoids trouble. Too low, and the medicine doesn't clear the worms. Too high, and side effects start to pop up—think nausea, vomiting, stomach pain, or even muscle weakness. Some folks might try to guess or "eyeball" the amount if packaging is unclear, but this isn't safe. A proper prescription and real measuring tools, like dosing cups or syringes found at any pharmacy, make a big difference. In busy clinics, doctors double-check math before sending any child home with medication.
Years ago, I watched a neighbor try over-the-counter piperazina for her toddler without clear dosing instructions. The child had a rough night with belly pain and vomiting. After a rushed clinic visit, doctors explained the dose was too high. It sticks with me—access to good information and measuring tools matters just as much as the medicine itself.
Piperazina stands as a safe option for most people, but certain groups—pregnant women, those with liver or kidney trouble, or people who suffer from seizure disorders—need extra care. They should talk to a doctor before any treatment starts, even if the infections seem mild.
Clear instructions make all the difference. That means asking questions in the pharmacy, especially about how much to give and when. The World Health Organization and CDC keep dosage guidelines up to date online. Doctors, especially in schools and clinics where pinworm outbreaks go around, look up these numbers each year. When parents or caregivers remember to wash bedding, clip fingernails short, and encourage handwashing, treatment works better. These steps break the worm cycle at home.
Education grows in importance. Pharmacies and clinics that post clear guides on deworming make it less likely that parents misdose. Schools joining in with awareness talks help keep families in the loop. In the end, knowing the right dose saves money, reduces side effects, and protects families—something every community can support.
Piperazine once popped up often in doctor’s offices for treating pinworm and roundworm infections. It worked well for pinworms, managing to flush them out so kids could return to class and adults could sleep better without itching. Docs and pharmacists see its benefits, but like every old-school remedy, piperazine brings its own set of surprises. Focusing on real-world experience, the biggest question that comes from patients and parents: does it bring side effects that matter?
Most people swallow a dose of piperazine and move on with their day. Stomach grumbles, maybe a little loose stool—that’s the story for many. Still, a chunk of folks notice queasy feelings, headache, or cramps after taking it. For kids, the taste can set off gagging or spitting it out, bruising the nerves of parents already frustrated with worms.
Doctors have seen other less common problems. Rash and itching sometimes appear. A couple of patients even complained about tingling hands and feet. There have been cases where the drug set off dizziness, confusion, and slurred speech, especially when someone took too high a dose or used piperazine for longer than directed.
Researchers have traced most side effects back to how piperazine messes with nerve signals in the worms, paralyzing them, but its effect doesn’t stop there. In rare cases, it nudges nerves in people, too. The World Health Organization points out that folks with kidney problems or seizure history run bigger risks. Piperazine can build up in the bloodstream if kidneys aren’t healthy, leading to trouble. Even healthy people should not mix piperazine with alcohol, barbiturates, or depressants—this combo causes sleepiness and, sometimes, more dangerous nervous system sludge.
Newer medicines now lead the fight against worms, so piperazine gets used less in big-city hospitals or pharmacies with more options. Still, in clinics without easy access to brand-name pills, piperazine is still stocked on the shelves. The cost stays low, and in many countries, it’s easy to hand out. Simple access, easy dosing, and a long track record explain why this medicine holds ground in some regions. Yet, that old track record isn’t spotless.
Worm outbreaks in schools or crowded families remind people why medicines like piperazine earn their spot. To cut down the risk of side effects, doctors encourage clear instructions—avoid double dosing, don’t use it for longer than prescribed, and keep it away from folks with kidney trouble or epilepsy. Families can protect kids by washing hands, keeping nails trimmed, and tackling bedding with high-heat laundry. Clean habits can cut down how often anyone needs a round of worm medicine in the first place.
Pharmacists and doctors agree that honest conversations matter. If you or your kid need worm medicine, don’t skip talking about other health issues. Report cramps, weird rashes, or any confusion right away. The pharmacy shelf holds lots of answers, but every medicine—old or new—deserves steady attention to safety, not quick fixes or shortcuts.
Piperazina shows up as a medication in many households, particularly in places where intestinal worms—a common problem among children—cause worry. Vets used to prescribe this medicine for dogs and cats too, especially in the past, when safer, more targeted treatments weren't around. The usual prescription targets roundworm infections. With so many safer, more effective options on the market, it only makes sense to question if Piperazina deserves a spot in your medicine cabinet or your pet’s care plan.
Doctors used to prescribe Piperazina for pinworm and roundworm infections in children, but medical science doesn’t stand still. Current pediatric guidelines show a clear shift toward newer drugs like mebendazole and albendazole, which not only work better but also cause fewer side effects. Piperazina sometimes triggers nausea, abdominal pain, and allergic reactions. Kids often react more strongly to these effects than adults.
Mistakes with dosage can lead to even scarier effects. Too much can bring convulsions or muscle weakness. Given the wide range of safer and more effective alternatives, most pediatricians won’t consider Piperazina unless nothing else is available. If a health professional still prescribes it, you should always ask why, and what other options exist.
People once turned to Piperazina for worms in their pets, mostly dogs and cats. It’s true—before the arrival of modern veterinary medicines, it offered a basic level of protection from roundworms. Times have changed. Today, products like praziquantel and milbemycin oxime protect against a wider range of parasites and deliver better results. With more precise dosing and fewer negative effects, they have become the go-to choices among veterinarians.
Pets are sensitive to medications designed for humans. The margin for error is slim. Giving the wrong amount of Piperazina can end badly, especially for young, small, or sick animals. Salivation, tremors, and difficulty walking are just a few signs of toxicity in pets given this drug by mistake or in excess. Whenever worm infections are suspected in a pet, a trip to the vet brings peace of mind and protects the animal from outdated, potentially risky medicines such as Piperazina.
The World Health Organization recommends mebendazole or albendazole for intestinal parasites in people. In the last decade, medical journals have tracked a drastic drop in Piperazina use and highlighted the decrease in side effects as a result. The American Veterinary Medical Association catalogs drugs with better safety records and broader coverage of possible parasites than Piperazina ever provided.
Relying on trustworthy, up-to-date care always puts children and pets first. Sticking with older treatments like Piperazina puts them at risk for the sake of convenience or cost. With resistant parasites becoming more common, the guidance from healthcare and veterinary experts keeps changing. Pharmacy shelves carry modern medicines for a good reason: years of clinical trials and community-level monitoring show people and animals recover faster and experience fewer side effects.
Families and pet owners—like me—face tough choices at times. Everyone wants the quickest fix, but easy solutions are not always the safest. Seeking professional advice and choosing medicines backed by years of research is the surest way to bring health without extra worry.
Ask anyone who grew up in many Latin American countries, and they'll remember PIPERAZINA as a familiar name from their childhood medicine cabinet. This worm treatment, used to control pinworms and roundworms, often entered households through word of mouth or recommendations from pharmacists. In some places, people picked it up from the local drugstore without thinking much about doctor visits. In others, laws tightened, and getting a bottle meant a prescription in hand.
Walk into a pharmacy in Mexico or Brazil, and the story changes compared to Spain or the United States. Each country follows its own rules for buying medicines like PIPERAZINA. For example, in Spain and the US, health authorities treat even older parasite medicines like PIPERAZINA with caution, mostly because of concerns about side effects or misuse. You usually won't find it on over-the-counter shelves. A doctor’s handwriting often opens the doors to these medications. There's good reason behind it. Kids tend to show vague gut symptoms, but true worm infections should see confirmation before treatment. Doctors and pharmacists want to avoid over-treating kids or missing other health problems.
People sometimes assume all “simple” medicines stay safe. That’s not always the case for worm treatments. Give PIPERAZINA in the wrong situation, and all sorts of other conditions could get missed. Allergic reactions, dizziness, or loose stools do pop up. Worse still, resistance can develop if an entire community relies too much on a single medicine. When parents rely on street advice or informal sales, small problems can turn into big ones. Adults treating themselves might skip what looks like unimportant warnings, risking their own health.
Most European and North American countries move medications behind the pharmacy counter to give doctors and pharmacists a chance to check for problems. Medical oversight stops people from misdiagnosing or reusing old medicines without checking freshness or the right dosage. Over time, many regions replaced PIPERAZINA with other worm treatments, ones that clear infections more quickly and with fewer side effects. Today’s guidelines often recommend newer drugs, meaning PIPERAZINA prescriptions are rare and often come with closer supervision. Pharmacies that do keep it usually demand a prescription, mostly to protect the buyer.
There’s no single answer for every country. Better education stands out as the most important step. If parents know the telltale signs of genuine worm infections, fewer mistakes follow. Pharmacies run by skilled professionals give better advice, too. Health systems that guide patients instead of making medicine too hard to reach see better outcomes. I remember my grandmother double-checking every bottle of medicine with a pharmacist she trusted, not just because rules told her to. She knew the risks, and that made all the difference.
Access to medications like PIPERAZINA should balance safety and availability. Some places choose the prescription route for a reason—protecting people from unnecessary or unsafe treatments. Understanding local laws and leaning on trained medical advice beats guessing every time. That’s what keeps families safe and medicines effective.
| Names | |
| Preferred IUPAC name | Piperazine |
| Other names |
Dietilendiamina Hexahidropirazina |
| Pronunciation | /pi.pe.raˈθi.na/ |
| Identifiers | |
| CAS Number | 110-85-0 |
| Beilstein Reference | 1718737 |
| ChEBI | CHEBI:8107 |
| ChEMBL | CHEMBL418 |
| ChemSpider | 7287 |
| DrugBank | DB00542 |
| ECHA InfoCard | ECHA InfoCard: 0000309-61-3 |
| EC Number | 110-85-0 |
| Gmelin Reference | 8759 |
| KEGG | C00535 |
| MeSH | D010929 |
| PubChem CID | 4815 |
| RTECS number | **UG3675000** |
| UNII | J17X43Y12C |
| UN number | UN2579 |
| Properties | |
| Chemical formula | C4H10N2 |
| Molar mass | 86.14 g/mol |
| Appearance | White crystalline powder |
| Odor | Ammoniacal |
| Density | 1.03 g/cm³ |
| Solubility in water | Freely soluble |
| log P | 1.08 |
| Vapor pressure | 0.0065 mmHg (25°C) |
| Acidity (pKa) | 9.8 |
| Basicity (pKb) | 4.27 |
| Magnetic susceptibility (χ) | -69.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.465 |
| Viscosity | 13.5 cP |
| Dipole moment | 2.39 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 274.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -7.2 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3823.8 kJ/mol |
| Pharmacology | |
| ATC code | QN05AG03 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes severe skin burns and eye damage. May cause an allergic skin reaction. Toxic to aquatic life with long lasting effects. |
| GHS labelling | GHS05, GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Danger |
| Hazard statements | H302, H312, H332, H319, H335, H373 |
| Precautionary statements | P264, P270, P273, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 1-3-0 |
| Flash point | 85°C |
| Autoignition temperature | 444 °C |
| Explosive limits | 3.4–20.4% |
| Lethal dose or concentration | LD50 oral rat 2,800 mg/kg |
| LD50 (median dose) | LD50 (median dose): 2,800 mg/kg (oral, rat) |
| NIOSH | NIOSH: TX7525000 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) of PIPERAZINA: "5 mg/m3 |
| REL (Recommended) | 2 g |
| IDLH (Immediate danger) | 150 ppm |
| Related compounds | |
| Related compounds |
Hexamethylenetetramine EDTA Triazines Morpholine |
